lobbying_activities: 1261603

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1261603	994b6c9e-08db-4d11-8503-36be36a30e3f	Q2	LOPER CONSULTING LLC	400545627	TEVA PHARMACEUTICALS USA	2012	second_quarter	LBR	S. 27 Preserve Access to Generic Drugs; S. 1882 Fair and Immediate Release of Generic Drugs; S. 2295 Patient Safety and Generic Labeling Improvement Act of 2012	HOUSE OF REPRESENTATIVES,SENATE	51000		0	0	2012-07-13T10:16:10.510000-04:00